Prudential Financial’s Audentes Therapeutics, Inc BOLD Stock Holding History

Prudential Financial’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-82,570	Closed	-$4.94M	–	2505
2019 Q4	$4.94M	Buy	82,570 +68	+0.1%	+$2.55K	0.01%	1131
2019 Q3	$2.32M	Buy	82,502 +4,284	+5%	+$146K	﹤0.01%	1517
2019 Q2	$2.96M	Buy	78,218 +57,210	+272%	+$2.2M	﹤0.01%	1395
2019 Q1	$820K	Buy	+21,008	New	+$602K	﹤0.01%	1945

Prudential Financial's BOLD Position: Q1 2020 in Review

Prudential Financial sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 82,570 shares — an estimated $4.94M sold.

Prudential Financial first reported a position in BOLD in Q1 2019 and held it in 4 quarters. The position peaked at $4.94M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Prudential Financial reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Prudential Financial sold 82,570 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.94M.
Prudential Financial first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 4 quarters.
Prudential Financial's Audentes Therapeutics, Inc position peaked at $4.94M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Prudential Financial's 13F filing for Q1 2020, filed 12 May 2020.